LeMaitre Vascular, Inc.

NASDAQ:LMAT

Medical - Instruments & Supplies

Healthcare
$75.58 +1.74%

+$1.60 today

Market cap
$1.73B
Beta
0.52
P/E (TTM)
34.3
EPS (TTM)
$2.74
Dividend yield
0.96%
52W Low $79.01High $118.01

Volume 0.22M

Average 0.26M

LMAT EBITDA Margin

EBITDA as a percentage of revenue.

LeMaitre Vascular, Inc.NASDAQ: LMAT

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 35.5%

EBITDA Margin was 35.5% in Q1 FY2026, up 5.3 pp from a year earlier. On a trailing-twelve-month basis it was 37.6%, up 5.3 pp year over year. Over 3 fiscal years it widened by 13.5 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 34.9% for the fiscal year ending Dec 2026, down from 36.4% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
35.5%-2.1 pp QoQ
Last fiscal yearDec 2025
36.4%+6.0 pp YoY
LTMMar 2026
37.6%+5.3 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+5.3 pp+5.2 pp-0.1 pp
1 year+6.0 pp-1.5 pp-7.5 pp
3 years+13.5 pp-0.9 pp-14.4 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
36.4%
Year-over-year change
+6.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How LMAT compares with its peers on the latest reported figures

  • LMAT's LTM Mar 2026 EBITDA Margin of 37.6% is the highest of the 8 companies compared; the peer median is 14.8%.
  • Its year-over-year change of +5.3 pp is the highest of 8, against a peer median of -0.0 pp.
  • Over three fiscal years its change of +13.5 pp compares with a peer median of +3.8 pp.
LMAT Competitors Peer median
EBITDA Margin for LMAT and competitors
Company Period LTM level YoY 3-year change
LMATLeMaitre Vascular, Inc.LTM Mar 202637.6% +5.3 pp+13.5 pp
BSXBoston Scientific CorporationLTM Jun 202627.6% +2.2 pp+3.8 pp
MDTMedtronic plcLTM Jul 202627.3% +0.0 pp-0.9 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202621.2% -0.0 pp+6.2 pp
PENPenumbra, Inc.LTM Jun 202614.8% -0.4 pp+12.4 pp
AORTArtivion, Inc.LTM Mar 202614.2% +5.1 pp+6.3 pp
ANGOAngioDynamics, Inc.LTM Feb 2026-1.7% -1.9 pp-2.9 pp
TFXTeleflex IncorporatedLTM Jun 2026-6.1% -25.9 pp-11.0 pp
Peer median (excluding LMAT) 14.8%-0.0 pp+3.8 pp

Competitors are the stored peer set for LMAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue154.42M161.65M193.48M219.86M249.6M
Cost of Revenue53.04M56.76M66.44M68.96M71.06M
Gross Profit101.38M104.9M127.05M150.9M178.54M
Gross Margin65.7%64.9%65.7%68.6%71.5%
Research & Development11.8M13.29M16.97M15.65M14.14M
Selling, General & Admin53.16M61.67M72.89M83M96.49M
Operating Expenses64.96M78.07M90.34M98.65M110.63M
Depreciation & Amortization9.48M9.43M9.52M9.67M10.42M
EBITDA45.98M36.92M48.99M66.75M90.79M
EBITDA Margin29.8%22.8%25.3%30.4%36.4%
Operating Income36.43M26.83M36.71M52.26M67.91M
Operating Margin23.6%16.6%19.0%23.8%27.2%
Interest Income197K986K3.08M4.95M13.09M
Interest Expense2.22M00205K5.18M
Other Income / Expenses(2.14M)661K2.76M4.62M7.27M
Income Before Tax34.29M27.49M39.48M56.88M75.18M
Pre-Tax Margin22.2%17.0%20.4%25.9%30.1%
Income Tax Expense7.38M6.85M9.37M12.84M17.45M
Net Income26.91M20.64M30.11M44.04M57.73M
Net Margin17.4%12.8%15.6%20.0%23.1%
EPS (Basic)1.270.941.361.962.55
EPS (Diluted)1.250.931.341.932.52
Weighted Avg Shares21.16M21.98M22.22M22.45M22.64M
Weighted Avg Shares (Diluted)21.48M22.17M22.42M22.78M22.93M

LeMaitre Vascular, Inc.

NASDAQ:LMAT

Intrinsic Alpha fair value

Locked

Current Price

$75.58

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.